Two different estimates of college stimulant use may both be accurately quoted while measuring different things. A lifetime report is not a past-month report; nonmedical prescription-stimulant use is not necessarily amphetamine use; and use intended to help studying does not demonstrate better academic performance. A 2011 review by Smith and Farah explains why these distinctions belong beside the percentage.
This is historical evidence. The review describes surveys and experiments available at that time. Its estimates should not be presented as the prevalence on today’s campuses, or used to infer whether a particular student consumed a drug.
What did this review examine?
The authors examined both the epidemiology of nonmedical prescription-stimulant use and controlled evidence about cognition in healthy people. The prescription drugs of principal interest were methylphenidate and amphetamine formulations, including dextroamphetamine. They are not interchangeable exposures, and the review did not administer a new drug regimen to one pooled student cohort.
Its survey section identified at least 25 college-student studies by the end of 2009. These differed in geographical coverage, recruitment, sample size, response rate, drug questions and the interval participants were asked to recall. The presence of numerous surveys does not make every percentage an estimate of the same underlying quantity.
How much difference does the recall interval make?
The review describes a 2001 survey of 10,904 students at 119 public and private US colleges and universities. It reported lifetime nonmedical prescription-stimulant use of 6.9%, past-year use of 4.1% and past-month use of 2.1%. These are three estimates from the same survey, as summarized by the review.
| Reported window | Estimate | Interpretive boundary |
|---|---|---|
| Lifetime | 6.9% | Does not mean use continued into the survey month |
| Past year | 4.1% | Does not specify regular or daily use |
| Past month | 2.1% | Does not specify a dose, concentration or event-time impairment |
The estimates concern the prescription-stimulant category used in that survey. They should not be relabeled as methamphetamine prevalence or the percentage of students misusing amphetamine specifically. The study year is part of the finding, not optional background.
Does “nonmedical” always mean the same thing?
No. Some studies excluded everyone with a prescription from the nonmedical-use group, regardless of how or why the person took the drug. Others classified use by purpose and could count nonmedical use by someone who also had a prescription. One study in the review did not specify its definition.
Those rules can classify the same hypothetical behavior differently. A prescription holder taking medication outside the intended medical purpose may be excluded under the first rule and included under the second. Comparing the resulting percentages without the rules risks treating a measurement difference as a behavioral difference.
Drug coverage also matters. A question naming only Ritalin need not capture other methylphenidate brands, and a broad stimulant question can encompass substances outside the review’s prescription-drug focus. The authors noted that historical national surveys sometimes grouped prescription stimulants with other stimulants, including methamphetamine. An estimate from that combined category cannot establish the rate for each component.
Can a high percentage from one campus represent all students?
A sample’s size does not resolve every question about whom it represents. Some reviewed studies covered multiple institutions; others recruited within a single campus or even classes in one department. Fraternity-only samples addressed a selected student group. The review also reported wide variation in response rates, including approximately 93.8% in one survey and 10% in another.
A low response rate raises the possibility that respondents differed from nonrespondents. A high response rate within a selected class still does not turn that class into a representative national sample. Recruitment frame and participation are separate parts of generalizability.
The review similarly cautioned against treating a voluntary magazine-reader poll on cognitive enhancement as population prevalence. People choosing to answer a topic-specific poll may have unusual interest or experience. That observation challenges generalization from the poll; it does not prove the direction or exact size of its selection bias.
Does past-year use mean frequent use?
No. The survey literature described sporadic as well as more frequent use. Some students reported taking stimulants around examinations; other respondents used more regularly. A past-year yes/no item can place both patterns in the same category.
Frequency among people who reported use also has a different denominator from prevalence among all surveyed students. For example, a percentage describing weekly use within a user subgroup should not be applied to an entire campus. Nor does an episode count identify tablet strength, formulation, route or measured exposure.
Does a study-related motive establish cognitive benefit?
Students commonly reported concentration, studying, memorization, alertness or grades as motives. Surveys also recorded recreational use, staying awake, appetite-related motives and other reasons. Motive categories could overlap.
These answers describe the respondents’ purposes and beliefs. They do not measure how much was learned, establish a higher examination score or show that a pharmacological effect caused improved work. Smith and Farah treated controlled, masked drug–placebo experiments as a separate evidentiary question. Their cognitive review concerned oral methylphenidate or dextroamphetamine in nonelderly adults, with task-specific findings and uncertainty; it did not validate every reported student benefit.
How should an estimate be explained to a client?
Identify the drug category, population, collection year, recall window and definition of nonmedical use before drawing a comparison. Then distinguish prevalence among all respondents from frequency among users and motivation among those reporting a particular purpose. Keep self-report limitations visible.
These historical surveys can explain patterns of reported behavior and the difficulty of measuring them. They cannot diagnose an individual’s drug use, dependence, impairment or responsibility for a specific event. That inference would require evidence about the individual rather than a campus-level percentage.
Scientific source
Smith ME, Farah MJ. Are Prescription Stimulants “Smart Pills”? The Epidemiology and Cognitive Neuroscience of Prescription Stimulant Use by Normal Healthy Individuals. Psychological Bulletin. 2011;137(5):717–741. doi:10.1037/a0023825. Full-text author manuscript. Historical review; survey findings above are described through this supplied review, rather than presented as independently reanalyzed primary data.
Leave a Reply